Keywords: bayer, presents, results, xarelto, trial, aha, germany

Bayer presents results of Xarelto trial at AHA

Article | 17 November 2008

Print This

Germany's Bayer Schering Pharma presented findings from a Phase II study of the novel oral anticoagulant Xarelto (rivaroxaban) as a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in